indocyanine green has been researched along with Candidiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stanescu-Segall, D; Zonnevylle, KE | 1 |
| Baglivo, E; Bagnoud, M; Leuenberger, PM; Safran, AB; Seghelmeble, C | 1 |
2 other study(ies) available for indocyanine green and Candidiasis
| Article | Year |
|---|---|
Intravitreal Bevacizumab for Treatment of Bilateral Candida Chorioretinitis Complicated with Choroidal Neovascularization.
Topics: Aged, 80 and over; Amphotericin B; Angiogenesis Inhibitors; Antifungal Agents; Bevacizumab; Candidiasis; Chorioretinitis; Choroidal Neovascularization; Coloring Agents; Drug Therapy, Combination; Eye Infections, Fungal; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Subretinal Fluid; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2020 |
Indocyanine green angiographic features in endogenous Candida chorioretinis.
Topics: Adult; Antifungal Agents; Candidiasis; Chorioretinitis; Female; Fluconazole; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Opportunistic Infections; Treatment Outcome; Visual Acuity | 2003 |